Hagmann W - Search Results

1

Schamschula E, Lahnsteiner A, Assenov Y, Hagmann W, Zaborsky N, Wiederstein M, Strobl A, Stanke F, Muley T, Plass C, Tümmler B, Risch A. Schamschula E, et al. Among authors: hagmann w. Epigenetics. 2022 Aug;17(8):837-860. doi: 10.1080/15592294.2021.1959976. Epub 2021 Aug 20. Epigenetics. 2022. PMID: 34415821 Free PMC article.

2

Immunotyping of clinically divergent p.Phe508del homozygous monozygous cystic fibrosis twins.

Schamschula E, Hagmann W, Assenov Y, Hedtfeld S, Farag AK, Roesner LM, Wiehlmann L, Stanke F, Fischer S, Risch A, Tümmler B. Schamschula E, et al. Among authors: hagmann w. J Cyst Fibros. 2021 Jan;20(1):149-153. doi: 10.1016/j.jcf.2020.06.009. Epub 2020 Jun 13. J Cyst Fibros. 2021. PMID: 32540173 Free article.

3

Identification of HERC5 and its potential role in NSCLC progression.

Wrage M, Hagmann W, Kemming D, Uzunoglu FG, Riethdorf S, Effenberger K, Westphal M, Lamszus K, Kim SZ, Becker N, Izbicki JR, Sandoval J, Esteller M, Pantel K, Risch A, Wikman H. Wrage M, et al. Among authors: hagmann w. Int J Cancer. 2015 May 15;136(10):2264-72. doi: 10.1002/ijc.29298. Epub 2014 Nov 9. Int J Cancer. 2015. PMID: 25353388 Free article.

4

Expression, subcellular localization and putative function of platelet-type 12-lipoxygenase in human prostate cancer cell lines of different metastatic potential.

Timár J, Rásó E, Döme B, Li L, Grignon D, Nie D, Honn KV, Hagmann W. Timár J, et al. Among authors: hagmann w. Int J Cancer. 2000 Jul 1;87(1):37-43. doi: 10.1002/1097-0215(20000701)87:1<37::aid-ijc6>3.0.co;2-l. Int J Cancer. 2000. PMID: 10861450 Free article.

5

Evidence linking CD44-positive cells and gemcitabine resistance in pancreatic cancer cells: need for further substantiation.

Hagmann W, Jesnowski R, Matthias Löhr J. Hagmann W, et al. Int J Cancer. 2010 Jul 1;127(1):246-7. doi: 10.1002/ijc.25016. Int J Cancer. 2010. PMID: 19877122 Free article. No abstract available.

6

Molecular identification, localization and function of platelet-type 12-lipoxygenase in human melanoma progression, under experimental and clinical conditions.

Rásó E, Döme B, Somlai B, Zacharek A, Hagmann W, Honn KV, Tímár J. Rásó E, et al. Among authors: hagmann w. Melanoma Res. 2004 Aug;14(4):245-50. doi: 10.1097/01.cmr.0000138479.00897.d8. Melanoma Res. 2004. PMID: 15305153

7

EGF-receptor tyrosine kinase and 12-lipoxygenase activity regulate expression of 12-lipoxygenase in human tumor cells.

Hagmann W, Borgers S. Hagmann W, et al. Adv Exp Med Biol. 1997;407:9-14. doi: 10.1007/978-1-4899-1813-0_2. Adv Exp Med Biol. 1997. PMID: 9321925 No abstract available.

8

Interdependence of gemcitabine treatment, transporter expression, and resistance in human pancreatic carcinoma cells.

Hagmann W, Jesnowski R, Löhr JM. Hagmann W, et al. Neoplasia. 2010 Sep;12(9):740-7. doi: 10.1593/neo.10576. Neoplasia. 2010. PMID: 20824050 Free PMC article.

9

12-lipoxygenase expression in human melanoma cell lines.

Timár J, Rásó E, Honn KV, Hagmann W. Timár J, et al. Among authors: hagmann w. Adv Exp Med Biol. 1999;469:617-22. doi: 10.1007/978-1-4615-4793-8_89. Adv Exp Med Biol. 1999. PMID: 10667390

10

12-Lipoxygenase in Lewis lung carcinoma cells: molecular identity, intracellular distribution of activity and protein, and Ca(2+)-dependent translocation from cytosol to membranes.

Hagmann W, Gao X, Zacharek A, Wojciechowski LA, Honn KV. Hagmann W, et al. Prostaglandins. 1995 Jan;49(1):49-62. doi: 10.1016/0090-6980(94)00005-h. Prostaglandins. 1995. PMID: 7792391

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

141 results

Search Page